Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Putney, Inc.
PORTLAND, Maine, June 12, 2014 /PRNewswire/ -- Jean Hoffman, president and CEO of Putney, Inc., was named the New England Ernst & Young (EY) Entrepreneur of the Year™ 2014 in the Life Sciences category in recognition of her success in building Putney into the largest generics company in the veterinary pharmaceutical industry. Upon receiving the award at EY's 28th annual Entrepreneur of the Year Awards Gala in New England, Hoffman credited her team who she said is "overcoming obstacles and accomplishing our goal of making pet healthcare more affordable." Under Hoffman's leadership, Putney is disrupting the veterinary market by developing and commercializing high quality, generic pet medicines where lack of competition has forced pet owners to pay inflated prices.
Hoffman says winning the award in the life sciences category underscores the world-class scientific program that Putney has developed to bring its five FDA-approved pet medicines to market since the company's launch in 2006. "The scientific and technical barriers to entry are high, which is one of the reasons why no one else has been able to develop an entire portfolio of FDA-approved generic pet medicines. Our heavy investment in R&D has produced the largest pipeline of new product launches in animal health," says Hoffman.
As a New England award winner, Hoffman is nominated to EY's national Entrepreneur Of The Year 2014 program. Award winners in several national categories, as well as the Entrepreneur Of The Year National Overall Award winner, will be announced at the annual awards gala in Palm Springs, California, on November 15, 2014. Previous national award winners include Putney board member Bruce Downey, who won as CEO of Barr Pharmaceuticals.
Putney is a pharmaceutical company committed to providing high quality, cost-effective generic medicines for pets. Putney's reliable supply of affordable drug options empowers veterinarians, allowing them to provide the best possible medicine at the best possible price, and supports pet owners, helping them afford to comply with veterinary recommendations. Putney's ongoing investment in research and development is focused on creating the next generation of generic veterinary products based on inputs from companion animal veterinarians and its industry partners. Learn more at www.putneyvet.com.
©2012 PR Newswire. All Rights Reserved.